Watch OFIX. Know when insiders buy.
One email the day a filing lands. Free.
Work order
53
WATCH · insiders 49, shorts 56
Insiders, 90 days
−$14K
net selling · 0 buys, 2 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $378.4MP/E —DIV YIELD —FCF YIELD -7.35%REV TTM $833.2M +3.0%NET INCOME −$61.7MNET DEBT $53.4M52W 8.95 – 16.23SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $210.9M | +3.8% | 71.0% | −$8.1M | −$15.8M | — | -0.39 | −$6.2M | $12.6M | −$18.9M | Aug 5 |
| Q1 2026 · Mar 31 | $196.7M | +1.6% | 70.9% | −$14.4M | −$20.9M | — | -0.52 | −$17.6M | $10.7M | −$28.3M | Aug 5 |
| Q4 2025 · Dec 31derived | $219.9M | +2.0% | 71.1% | $494K | −$2.2M | — | -0.05 | $27.7M | $10.9M | $16.8M | Feb 24 |
| Q3 2025 · Sep 30 | $205.6M | +4.6% | 72.2% | −$17M | −$22.8M | — | -0.57 | $12.4M | $9.9M | $2.5M | Nov 4 |
| Q2 2025 · Jun 30 | $203.1M | +2.3% | 68.7% | −$16M | −$14.1M | — | -0.36 | $11.6M | $7.1M | $4.5M | Aug 5 |
| Q1 2025 · Mar 31 | $193.6M | +2.7% | 62.8% | −$48.9M | −$53.1M | — | -1.35 | −$18.4M | $6.7M | −$25.1M | Aug 5 |
| Q4 2024 · Dec 31derived | $215.7M | +7.6% | 69.0% | −$11.5M | −$29.1M | — | -0.75 | $23.7M | $9.7M | $14.1M | Feb 24 |
| Q3 2024 · Sep 30 | $196.6M | +6.8% | 68.7% | −$18.9M | −$27.4M | — | -0.71 | $11.7M | $5.3M | $6.3M | Nov 4 |
| Q2 2024 · Jun 30 | $198.6M | — | 67.8% | −$24.9M | −$33.4M | — | -0.88 | $9M | $9.3M | −$360K | Nov 4 |
| Q1 2024 · Mar 31 | $188.6M | — | 67.5% | −$29.3M | −$36M | — | -0.95 | −$18.6M | $10.5M | −$29.1M | Nov 4 |
| Q4 2023 · Dec 31derived | $200.4M | — | 68.2% | −$18.3M | −$22.2M | — | -0.59 | −$6.7M | $14.6M | −$21.3M | Feb 24 |
| Q3 2023 · Sep 30 | $184M | — | 65.1% | −$24.4M | −$28.9M | — | -0.77 | $477K | $21.9M | −$21.4M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $822.3M | 68.8% | −$81.4M | −$92.2M | -11.2% | -2.33 | $33.3M | $34.6M | −$1.3M | — | — |
| FY2024 · to Dec 31 | $799.5M | 68.3% | −$84.6M | −$126M | -15.8% | -3.30 | $25.8M | $34.9M | −$9.1M | — | — |
| FY2023 · to Dec 31 | $746.6M | 65.1% | −$139.1M | −$151.4M | -20.3% | -4.12 | −$45.8M | $60.3M | −$106M | — | — |
| FY2022 · to Dec 31 | $460.7M | 73.2% | −$13.3M | −$19.7M | -4.3% | -0.98 | −$11.5M | $21.4M | −$32.9M | — | — |
| FY2021 · to Dec 31 | $464.5M | 75.3% | −$8.3M | −$38.4M | -8.3% | -1.95 | $18.5M | $17.8M | $690K | — | — |
| FY2020 · to Dec 31 | $406.6M | 74.9% | −$6.3M | $2.5M | 0.6% | 0.13 | $74.3M | $15.5M | $58.8M | — | — |
Every number comes from Orthofix Medical Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.